Number of Shares
9,316.00
Current Holdings Value*
$357,360.00
% of Portfolio
1.95%
Total Estimate Gain
$181,114.27
% of Total Estimate Gain
66.69%

Emerald Insights Fund's BridgeBio Pharma Inc Holding Summary

As of 2025-04-30, FINANCIAL INVESTORS TRUST held 9,316.00 shares of BridgeBio Pharma Inc(BBIO), totaling $357,360.00. This investment constitutes 1.95% of their stock portfolio, and FINANCIAL INVESTORS TRUST now holds 0% of the outstanding BridgeBio Pharma Inc(BBIO) stock.

The initial trade took place in 2024Q4. And since then Emerald Insights Fund has made 2 purchases of BBIO, at an average price of $26.91, for a total of 10,091.00 shares. In addition, there have been 1 sales at an average price of $33.91 for 775.00 shares. Based on historical transaction data and BBIO's current price of $45.77, Emerald Insights Fund's estimated gain on his BBIO holdings is $181,114.27, reflecting a 66.69% gain to date.

Emerald Insights Fund BBIO ($45.77) Holding Chart

Emerald Insights Fund BBIO ($45.77) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1